If I understand correctly BP2 (UP & OM) as well as P P2 interim results are being done to satisfy the requests/wants of interested BP's. Why would they want data at that stage instead of waiting for the trial(s) completion?
I don't claim to know the answer but IMO a deal could result from the interim data if it is very good.Otherwise why bother?
Kelt
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links